Evidence map›Paper›PMID 26464580›Full record

ArticleChinese medicine2015

Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice.

Hai-Tao Xiao, Jiao Peng, Dong-Dong Hu, Cheng-Yuan Lin, Bin Du, Siu-Wai Tsang, Ze-Si Lin, Xiao-Jun Zhang, Feng-Ping Lueng, Quan-Bin Han and 1 more

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Antioxidants (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Hai-Tao XiaoSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong ; School of Pharmacy, Guiyang Medical University, Guiyang, 550004 China.
Jiao PengDepartment of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Dong-Dong HuSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong ; School of Chinese Medicine, Shanghai University of Chinese Medicine, Shanghai, 200030 China.
Cheng-Yuan LinSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Bin DuSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Siu-Wai TsangSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Ze-Si LinSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong ; School of Fundamental Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006 China.
Xiao-Jun ZhangSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong ; School of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006 China.
Feng-Ping LuengSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Quan-Bin HanSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Zhao-Xiang BianSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Hong Kong Baptist University · HKChinese University of Hong Kong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundQing-dai powder (QDP), comprising Indigo naturalis (Qing-dai) and dried alum (Ku-fan), was used in Chinese medicine to treat the conditions associated with mucosal hemorrhage, such as ulcerative colitis (UC). This study aims to investigate the effects and potential mechanism of QDP on dextran sulfate sodium (DSS)-induced acute colitis in mice and to examine the regulatory effects of QDP on macrophages.

methodsSeven- to eight-week-old male C57BL/6 mice were challenged with 2.0 % DSS in drinking water for 5 days and then the colitic mice were arbitrarily allocated into five groups (n = 10 for each group). QDP (0.77, 1.54 and 3.08 g/kg) and sulfasalazine (SASP) (0.20 g/kg) were orally administered for 7 days. The disease activity index was determined by scores of body weight loss, diarrhea and rectal bleeding; histological signs of damage was analyzed by H&E staining; myeloperoxidase activity was measured by colorimetric method, levels of proinflammatory cytokines were determined by ELISA; changes in macrophages in the colon were analyzed by immunohistochemistry (IHC) and flow cytometry. Lipopolysaccharide (LPS)-induced RAW264.7 cells were treated with or without QDP, then the production of TNF-α and IL-6 were measured by ELISA; and protein molecules such as COX-2, iNOS, IкB-α were determined by Western blot.

resultsOral administration of QDP at dosages of 1.54 and 3.08 g/kg significantly reduced disease activity index on day 12 (P < 0.001 for 1.54 g/kg and P < 0.0008 for 3.08 g/kg), colon shortening (P = 0.012 for 1.54 g/kg, P = 0.001 for 3.08 g/kg), histological damage (P < 0.001 for 1.54 g/kg, P < 0.001 for 3.08 g/kg) and colonic myeloperoxidase activity (P = 0.002 for 1.54 g/kg, P < 0.001 for 3.08 g/kg) of DSS-treated mice. Moreover, QDP treatment (1.54 and 3.08 g/kg) significantly decreased DSS-induced infiltration of macrophages, and production of TNF-α (P = 0.005 for 1.54 g/kg, P = 0.002 for 3.08 g/kg), IL-1β (P = 0.008 for 1.54 g/kg, P = 0.002 for 3.08 g/kg) and IL-6 (P = 0.011 for 1.54 g/kg, P = 0.004 for 3.08 g/kg) in colonic tissues, and also reduced serum MCP-1 levels (P = 0.001 for 1.54 g/kg, P < 0.001 for 3.08 g/kg). In RAW264.7 cells, QDP significantly suppressed LPS-induced production of TNF-α and IL-6 (Both P < 0.001 for 1.0 μg/mL QDP treatment) and expression levels of COX-2 (P = 0.002 and P = 0.001 for 1 and 3 μg/mL QDP treatment, respectively) and iNOS (P < 0.001 for 3 μg/mL QDP treatment) by inhibiting IкB-α degradation (P = 0.007 and P = 0.004 for 1 and 3 μg/mL QDP treatment, respectively) and NF-кB p65 nuclear translocation.

conclusionQDP suppressed the inflammatory responses of colonic macrophages in DSS-induced UC in mice and LPS-induced RAW264.7 cells.

Identifiers

PMID26464580
PMCPMC4604072
OpenAlexW2159186400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.